Bachir Alobeid

About

Bachir Alobeid, MD, is a Professor of Pathology & Cell Biology at Columbia University Irving Medical Center. He specializes in hematopathology, with expertise in a wide range of hematologic malignancies including acute leukemia, chronic leukemia, lymphomas, and pediatric leukemias. Dr. Alobeid serves as the Director of the Hematopathology Service at NewYork-Presbyterian / Columbia University Irving Medical Center. He completed his medical education at Damascus University School of Medicine in Syria, followed by internship and residency at Brooklyn Hospital Center. His fellowship training was conducted at Roswell Park Comprehensive Cancer Institute. Dr. Alobeid is a full member of the Society for Hematopathology, where he has held leadership roles including Chairperson of the Education Committee and Chairperson of the Membership Committee. He is also involved with the Association of Pathology Chairs and the Columbia University Vagelos College of Physicians and Surgeons Academy of Clinical Excellence. His research and clinical work focus on hematopathology, and he has been recognized with awards such as the Pickren Pathology Award and faculty teaching awards from Columbia University. Dr. Alobeid is actively engaged in education, research, and professional service within the field of pathology.

Research topics

• Biology
• Cancer research
• Genetics
• Engineering
• Engineering ethics
• Pathology
• Psychology
• Medicine
• Medical education
• Immunology

Selected publications

• The whole-genome landscape of Burkitt lymphoma subtypes

  Blood · 2019-09-26 · 200 citations

  articleOpen access

  Burkitt lymphoma (BL) is an aggressive, MYC-driven lymphoma comprising 3 distinct clinical subtypes: sporadic BLs that occur worldwide, endemic BLs that occur predominantly in sub-Saharan Africa, and immunodeficiency-associated BLs that occur primarily in the setting of HIV. In this study, we comprehensively delineated the genomic basis of BL through whole-genome sequencing (WGS) of 101 tumors representing all 3 subtypes of BL to identify 72 driver genes. These data were additionally informed by…

  PublisherOA PDFDOI

• Genetic and phenotypic characterization of indolent T-cell lymphoproliferative disorders of the gastrointestinal tract

  Haematologica · 2019-09-26 · 77 citations

  articleOpen access

  Indolent T-cell lymphoproliferative disorders of the gastrointestinal tract are rare clonal T-cell diseases that more commonly occur in the intestines and have a protracted clinical course. Different immunophenotypic subsets have been described, but the molecular pathogenesis and cell of origin of these lymphocytic proliferations is poorly understood. Hence, we performed targeted next-generation sequencing and comprehensive immunophenotypic analysis of ten indolent T-cell lymphoproliferative dis…

  PublisherOA PDFDOI

• Immunophenotypic Spectrum and Genomic Landscape of Refractory Celiac Disease Type II

  The American Journal of Surgical Pathology · 2021 · 44 citations

  Refractory celiac disease type II (RCD II), also referred to as "cryptic" enteropathy-associated T-cell lymphoma (EATL) or "intraepithelial T-cell lymphoma," is a rare clonal lymphoproliferative disorder that arises from innate intraepithelial lymphocytes. RCD II has a poor prognosis and frequently evolves to EATL. The pathogenesis of RCD II is not well understood and data regarding the immunophenotypic spectrum of this disease and underlying genetic alterations are limited. To gain further biol…

  PublisherDOI

• Entrustable Professional Activities in Hematopathology Pathology Fellowship Training: Consensus Design and Proposal

  Academic Pathology · 2021 · 16 citations

  Hematopathology fellowship education has grown in complexity as patient-centered treatment plans have come to depend on integration of clinical, morphologic, immunophenotypic, molecular, and cytogenetic variables. This complexity is in competition with the need for timely hematopathology care with stewardship of patient, laboratory, and societal resources. Accreditation Council for Graduate Medical Education Milestones provide a guidance document for hematopathology training, but fellows and the…

  PublisherOA PDFDOI

• Detection of Nonhematologic Neoplasms by Routine Flow Cytometry Analysis

  American Journal of Clinical Pathology · 2019-07-24 · 14 citations

  articleOpen accessSenior authorCorresponding

  OBJECTIVES: We investigated the ability of routine flow cytometry (FC) to detect nonhematologic neoplasms (non-HN) using antibody panels routinely used for the diagnosis of hematologic neoplasms. METHODS: FC analyses of 4,000 various diagnostic samples were retrospectively reviewed to identify cases in which an aberrant, viable CD45-negative, nonhematologic neoplastic population was detected by FC panels designed to evaluate hematologic neoplasms. RESULTS: A total of 57 (1.4%) diverse non-HNs we…

  PublisherOA PDFDOI

Frequent coauthors

• Govind Bhagat

  Columbia University

  253 shared

• Vundavalli V. Murty

  Herbert Irving Comprehensive Cancer Center

  113 shared

• Mahesh Mansukhani

  Columbia University Irving Medical Center

  67 shared

• Deborah W. Sevilla

  40 shared

• Daniela Hoehn

  Genmab (United States)

  36 shared

• Giorgio Cattoretti

  University of Milano-Bicocca

  35 shared

• Subhadra V. Nandula

  35 shared

• Adriana I. Colovai

  31 shared

Awards & honors

• Pickren Pathology Award: Presented by the Pathology Faculty…
• The Dr. Joseph G. Fink laboratory Medicine Faculty Teaching…
• The Dr. Karl Perzin Anatomic Pathology Faculty Teaching Awar…

Similar researchers at Columbia University

• Ottavio Arancioh-95
• Jonathan M. Baraschh-79
• Rando L. Allikmetsh-79